Veinplicity Impresses at KIMES 2016

Physeon had a successful tradeshow at KIMES in Seoul, South Korea, our first trade event in Asia. Interest in Veinplicity from Korean distributors, healthcare professionals and international visitors was immense. As at MEDICA 2015, our product demonstrations impressed attendees, showing how Veinplicity makes accessing veins easy and efficient. There was an expressed medical need for a device like Veinplicity and we walked away with new market segments, especially in South Korea. We are excited to participate in upcoming tradeshows in Shanghai, China and Tokyo, Japan this April.

#KIMES #Tradeshow #Distributors #Veinplicity


The Veinplicity device is CE marked and registered as a Class IIa medical device in the European Union and as a Class II medical device in Canada. We are seeking FDA approval. The device is manufactured within the ISO 13485 standard in the United States.

Featured Posts
Follow Veinplicity